239 results on '"Gentet J"'
Search Results
2. Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results
3. Stratégie de prise en charge de contages tuberculeux dans un service d’oncologie-pédiatrique
4. Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring
5. Atypical teratoid/rhabdoid tumour: 7-year event-free survival with gross total resection and radiotherapy in a 7-year-old boy
6. Accompagnement des enfants atteints de cancers: expérience de l'Association Sourire à la Vie
7. Parental consent in paediatric clinical research
8. Optimizing the surgical management of lung nodules in children with osteosarcoma: Thoracoscopy for biopsies, thoracotomy for resections
9. Subcutaneous lymphoblastic lymphomas. Expression of cellular adhesion molecules: 2 cases
10. A study of 28 flat bone osteosarcomas: prognostic factors and early and long-term outcome
11. 7.P.52 ARE TYROSINE KINASE RECEPTORS GOOD CANDIDATES IN PEDIATRIC OSTEOSARCOMAS FOR TARGETED THERAPIES?
12. New Adaptive Method for Phase I Trials in Oncology
13. Clinical, Radiological, Histopathological, Molecular Description and Identification of Prognostic Factors for Desmoplastic Infantile Gangliogliomas and Astrocytomas: A Multicentric Cohort Study
14. Outcome of Children Treated With Preradiation Chemotherapy for a High-Grade Glioma: Results of a French Society of Pediatric Oncology (SFOP) Pilot Study#
15. Physeal and epiphyseal extent of primary malignant bone tumors in childhood: Correlation of preoperative MRI and the pathologic examination
16. Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study
17. Dose-finding and pharmacokinetic study of weekly oxaliplatin in pediatric solid malignancies: 3257
18. Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy
19. Clinical Trials in Paediatric Oncology
20. Les soins intensifs en fin de vie chez les enfants, adolescents et jeunes adultes avec cancer : une étude populationnelle à partir des données du PMSI
21. High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine (vindesine), platinum] - doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot study
22. Pulmonary anthracosis in children
23. Use of Off-Label Targeted Therapies in Refractory Sarcomas: Analysis of Pediatric Data from the French Registry Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes
24. Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results A protocol of the French Pediatric Oncology Society (SFOP)
25. Zoledronate Does not Reduce the Risk of Treatment Failure in Osteosarcoma: Results of the French Multicentre Os2006 Randomised Trial
26. Use of Off-Label Targeted Therapies in Refractory Sarcomas: Analysis of Pediatric Data from the French Registry Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes.
27. CLINICAL TRIALS
28. DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
29. La dyspnée comme symptôme de fin de vie Revue de la littérature
30. Pediatric Medulloblastoma: Educational Long-term Outcome and Clinical Factors
31. Chimiothérapie métronomique en oncologie pédiatrique : effet de mode ou espoir réel ?
32. SFCE-P33 – Cancérologie – Ependymomes intracrâniens de l’enfant et radiothérapie bifractionnée focale post-opératoire
33. Status of topoisomerases in pediatric high grade osteosarcomas and their therapeutic and prognostic role
34. A study of 28 flat bone osteosarcomas: Prognostic factors, early and long-term outcome
35. Phase I study of temozolomide in combination with topotecan (TOTEM) in children with refractory or relapsed malignant tumors
36. Expression de l’ezrine dans les ostéosarcomes centraux de haut grade : corrélations pronostiques
37. Atypical teratoid/rhabdoid tumour: 7-year event-free survival with gross total resection and radiotherapy in a 7-year-old boy
38. Immunohistochemical expression of ezrin correlates with Event-free and overall survival in osteosarcomas
39. ITCC phase I study of erlotinib as single agent in children with refractory and relapsed malignant brain tumors and in combination with irradiation in newly diagnosed brain stem glioma
40. Ifosfamide versus cyclophosphamide: Long term gonadal effects in 166 male survivors of childhood cancer
41. Long-term evaluation of ifosfamide-related nephrotoxicity in children: The French experience
42. Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring
43. Traitement d'une candidose systémique résistante à l'amphotéricine B liposomale par l'ajout de la caspofungine chez un patient neutropénique
44. 246 INVITED Imatinib mesylate in recurrent solid tumours expressing KIT or PDGFR (phase II)
45. ITCC phase II study of imatinib mesylate in children with solid tumors expressing imatinib-sensitive tyrosine kinase receptors
46. Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies
47. A new IV busulfan fixed dosing for better exposure targeting in children undergoing allogeneic or autologous hematopoietic stem cell transplantation
48. Parental consent in pediatric clinical research
49. Bifocal Intracranial germinoma (BIG): Is there a place for localized radiation?
50. Clinical Trials in Paediatric Oncology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.